Category Archives: Press Releases

Survey reveals great progress made by biomedical research sector in Spain to be more open about animal research

The first report on the Spanish biomedical sector’s commitment to be more transparent about its research using animals, published today, has highlighted the great progress being made to improve openness.

Launched in 2016, the Transparency Agreement on Animal Research in Spain, (‘Acuerdo de transparencia sobre el uso de animales en experimentación científica en España’) now has more than 120 public and private research centres, universities and scientific societies as signatories. It contains four commitments for research centres in Spain to provide more information about animal research at their institutions.

1/ Speak with clarity about when, how and why animals are used in investigation.
2/Provide adequate information to the media and the general public about the conditions under which research using animals is carried out and the results obtained from them.
3/ Develop initiatives that improve knowledge and understanding by society about the use of animals in scientific research.
4/Report annually on progress and share experiences.

The report, (in Spanish) launched today at the Student Residence of the CSIC, in Madrid, assessing the development of the fourth commitment has been carried out by the European Animal Research Association (EARA), in partnership with the Spanish Society for Laboratory Animal Sciences (SECAL), a member of both the Spanish Confederation of Scientific Societies (COSCE) and EARA. Continue reading

Great Britain’s biomedical research statistics for 2017 indicate fewer animals used for second consecutive year

The latest figures released by the Home Office show a decrease in the overall use of animals in biomedical research in Great Britain’s public and private institutions.

These statistics for 2017 were presented to the UK Parliament under the terms of the Animals (Scientific Procedures) Act 1986 and demonstrate the continuing commitment of the British biomedical sector to openness and transparency about animal research, combined with an ongoing commitment to replace, reduce and refine the use of animals for every project, commonly known as the 3Rs.

The figures show that 3,789,373 experimental procedures were conducted in Great Britain [1] in 2017, 3.7% fewer than in 2016. Over 96% of the procedures on animals involved mice, fish, rats and birds while cats, dogs and non-human primates accounted for less than 0.2% of studies.

There was a significant fall in the number of procedures on dogs (3847 procedures) and on primates (2960 procedures), the lowest number for over 40 years for both species. Continue reading

Take responsibility and speak up on animal research in Germany, scientists are urged at EARA event

The German biomedical community has been urged at an EARA event in Berlin, to communicate more to the public, talk about values and explain why animal research is important, not just use ‘facts and figures’.

A panel of experts from research, animal welfare and the science media came together to discuss the topic Improving Openness in Animal Research in Germany at the Max Delbrück Center, Berlin, (MDC) in an event supported by the Federation of European Neuroscience Societies (FENS) and the Society for Neuroscience (SfN).

Setting the scene, EARA Executive Director, Kirk Leech, said that while progress had been made in Germany on communication there is still a significant reluctance within many academic institutions, and amongst scientists, towards conducting a more open and consistent dialogue with the public.

The sector needed to redress the balance by talking more about animal research. ‘The public hears the voice of animal activists in one ear and then nothing from the biomedical sector in the other ear,” he said.

Dr. Andreas Lengeling, animal research & welfare officer, Max Planck Society, explained how the Society developed a ‘4th R: responsibility’ for animal research, in addition to the 3Rs (replace, refine, reduce). The Society had also produced a White Paper setting out in detail its approach to animal research.

“Explaining your own ethical reasoning is something we have found is important for scientists,” he added. Continue reading

Dutch Parliament backs primate research

In response to calls to reduce the number of experiments with non-human primates (NHP) by up to 40% in the Netherlands the Dutch Parliament has now reached a compromise.

In two motions, the parliament acknowledged the importance of animal research (including NHP) for scientific and medical progress and has stated that the 40% reduction should relate to commercial research, a goal supported by the Biomedical Primate Research Center, which has been the focus of these controversial proposals.

In addition, responding to calls that NHP research should be centralised in the Netherlands, the Parliament said that this should only be done if the facilities agreed to the proposal themselves.

EARA Executive Director, Kirk Leech, said: “It is good to see that the Dutch Parliament has recognised the value of primate research in the country and is working with the sector to adopt proposals that are workable”

Switzerland’s 2017 animal research statistics indicate fewer animals used

The latest figures released by the Swiss Federal Veterinary Office (BLV) show a decrease in the overall use of animals in biomedical research in the Switzerland’s public and private institutions.

These statistics for 2017 are made available in compliance with Swiss law and demonstrate the continuing commitment of the Swiss biomedical sector to openness and transparency about animal research, combined with an ongoing commitment to replace, reduce and refine the use of animals for every project, commonly known as the 3Rs.

In particular, the figures show a reduction in the number of mice used and a 19% increase in the number of fish used. Within the overall biomedical sector, three categories – disease diagnosis, education and training, and environmental, including human and veterinary protection – show a significant increase in procedures carried out using animals. There was a decrease in the use of animals in the basic research and discovery, development and quality control categories. Continue reading

Agreement on transparency in animal research launched in Portugal

The public announcement of the Transparency Agreement on Animal Research in Portugal
will take place today (21 June 2018).

This initiative presented by the scientist Nuno Sousa has been proposed by the European Animal Research Association (EARA) and supported by the Portuguese Society of Sciences in Laboratory Animals (SPCAL) and is supported by 16 Portuguese institutions, from across the country, that use animals in biomedical and basic research.

The aim of the Transparency Agreement is to improve the Portuguese public’s understanding
and acceptability of animal research by promoting openness and transparency. The signatories
agreed to be more open and consistent with the public on their communication about the scientific, ethical and moral justifications for animal research.

This approach is based on the Transparency Agreement in Spain, launched in 2016, where
EARA co-operated with the Federation of Spanish Scientific Societies (COSCE) and the UK
Concordat on Openness on Animal Research.

Kirk Leech, of EARA, said: “This Transparency Agreement is a significant step forward for the
biomedical sector in Portugal. It will set high standards for openness and lead to a greater
understanding among the general public of the benefits of animal research, including the
contribution it makes to the studies of cancer and diseases of the brain.

“We also expect that most institutions in Portugal, that conduct animal research will eventually join the Agreement.”

The launch ceremony took place before the IV SPCAL Congress dedicated to the theme
“Quality and Transparency in Science involving Laboratory Animals”, in the School of Medicine
and the Life and Health Sciences Research Institute (ICVS) at University of Minho, in Braga. There followed a presentation by Prof. Doctor Nuno Sousa, neuroscientist and President of the
School of Medicine of the University of Minho; EARA Executive Director, Kirk Leech and the
President of SPCAL, Prof. Doctor Ricardo Afonso. Continue reading

Primate poposal by Netherlands government ‘will severely limit progress on biomedical research’.

EARA has responded to a call by the Dutch Science Minister for the Biomedical Primate Research Centre (BPRC), in the Netherlands, an EARA member, to draw up a proposal, by the beginning of next year, to reduce the number of experiments with no-human primates (NHP) by up to 40%.

Ahead of a debate, which took place in the Netherlands House of Representatives earlier this month, EARA wrote to Ingrid van Engelshoven, Minister of Education, Culture and Science and Carola Schouten, Minister of Agriculture, Nature and Food Quality, urging them not to set an artificial limit on the number of NHP used in research.

The letter, written by EARA, said that any reduction was “highly likely to severely limit the progress that can be made in both fundamental research and the development of innovative medicines and treatments for life-threatening diseases and infectious disease control”.

Currently the main areas of primate study are infectious diseases, neuroscience and fertility and foetal research. Primates are an important model for the development of vaccines and treatments for HIV/AIDS, Ebola, Zika and malaria and for investigations into treatments for conditions ranging from Alzheimer’s disease to Schizophrenia. They are also used in safety testing for new medicines and vaccines. Continue reading

Speakers announced for EARA/FENS communications event in Germany

Improving Openness and Animal Research in Germany – Free satellite event, Thursday, 12 July, FENS/EARA

The list of speakers for the free satellite event at the FENS Forum of Neuroscience has now been confirmed.

The event will discuss improving openness on animal research in communications with the general public, political decision makers and opinion formers in Germany. To attend please register here https://www.eventbrite.co.uk/e/improving-openness-and-animal-research-in-germany-tickets-45287347676

  • Kirk Leech, Executive Director, European Animal Research Association
    Kirk is Executive Director of EARA, th communications and advocacy organisation whose mission is to uphold the interests of biomedical research and healthcare development across Europe. Previously Kirk worked for the Association of the British Pharmaceutical Industry and  Understanding Animal Research, the UK’s leading advocacy group on the use of animals in medical research.
  • Dr. Andreas Lengeling, Animal Research & Welfare Officer, Max-Planck-Society
    Andreas, studied Biology at the University of Bielefeld and is the new animal research and animal welfare officer of the Max-Planck Society. He is responsible for the implementation of the society’s recent white paper on animal research. His role involves the support of 30 Max-Planck Institutes in all aspects of animal experimentation, which carry out life sciences in the society.
  • Volker Stollorz, Science Media Center, Germany
    Volker studied biology and philosophy at the University of Cologne and in 2015, became the founding CEO of the Science Media Center, a non-for profit organization that helps journalists find scientific expertise when science hits the headlines.
  • Dr.Thomas Kammertöns, Max-Delbrück-Center, Berlin
    Thomas is a staff scientist at the Institute of Immunology, Charité University Medical Centre, Berlin, and is interested in how the immune system influences the process of carcinogenesis.

Event details  Continue reading

EARA Brexit briefing published

EARA Brexit Taskforce Briefing on the potential implications for animal science in the UK and EU stemming from Brexit

EARA has brought together a group of organisations under a Brexit Taskforce. The Taskforce is comprised of the following organisations – EARA, ABPI, AnimalHealth Europe, Charles River Laboratories, Covance, Ellegaard Göttingen Minipigs, Envigo, GSK, Marshall BIoResources, National Office of Animal Health, Understanding Animal Research and the Wellcome Sanger Institute.

The Task Force has produced this briefing which addresses both the complexities and possible opportunities for animal science in Europe stemming from Exit. Read the briefing here

The aim of this initiative is to allow the wider biomedical sector the opportunity to raise concerns with both the 27 (through EU engagement) and UK authorities on outstanding and unresolved issues over Brexit and animal science. If you have any questions about the briefing or believe that your organisation would benefit from joining the Task Force please contact us at info@eara.eu

End

Another year of medical achievements thanks to animal research

A look back by EARA at some of the important discoveries in recent times

The last year has once again seen an impressive list of medical achievements globally, as scientists find better treatments for devastating diseases.

Among the breakthroughs reported are:

  • Human trials are now closer for an Ebola vaccine with a team at UW–Madison School of Veterinary aiming to produce an experimental vaccine (March 2018) that has already been proven to work safely in monkeys.
  • Researchers at University College London have announced (Dec 2017) that there is now hope for a way to stop Huntington’s disease, described as the biggest breakthrough in neurodegenerative diseases in 50 years.
  • 2017 Nobel Prize in Physiology or Medicine awarded with help of fruit fly (drosophila) study. The discoveries of the group of scientists who worked on the project show how plants, animals and humans co-ordinate their biological rhythms with the Earth’s daily cycle.

EARA Executive Director, Kirk Leech, said: “There is no doubt that we would not see the remarkable advances in biomedical research that have occurred recently, without the use of animals.

“While alternative methods to animal research, such as computer models and cell cultures are important, testing using animals remains the safest and most effective way to produce drugs and treatments for us all.”

Animal research is integral to ongoing research in areas such as spinal cord repair, stem cell treatments (Parkinson’s and Alzheimer’s), gene therapy (muscular dystrophy, diabetes) and molecularly targeted cancer medicines.

Historically, animal research has also led to new diagnostic tests for early treatment (cancer, heart disease); and effective treatments for serious illnesses (diabetes, leukemia, HIV/AIDS, cardiovascular disease).

The same research often helps humans and animals (treatments for arthritis, neurological disorders, organ transplants, cancer therapies) and contributes to farm animal welfare and techniques to save endangered species.

End